Accumulation of Tau Protein, Metabolism and Perfusion-Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS)

Neuroimaging in the context of examining atypical parkinsonian tauopathies is an evolving matter. Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) bring tools, which may be reasonable in supplementary examination, however cannot be interpreted as a gold stand...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in neurology Vol. 10; p. 101
Main Authors: Alster, Piotr, Madetko, Natalia Katarzyna, Koziorowski, Dariusz Mariusz, Królicki, Leszek, Budrewicz, Sławomir, Friedman, Andrzej
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 14-02-2019
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Neuroimaging in the context of examining atypical parkinsonian tauopathies is an evolving matter. Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) bring tools, which may be reasonable in supplementary examination, however cannot be interpreted as a gold standard for correct diagnosis. The review presents advantages and limitations of tau radiotracers in PET, metabolic PET and perfusion SPECT. The aim of this paper is to highlight the possibilities and boundaries in the supplementary examination of tauopathic parkinsonian syndromes.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Edited by: Giuseppe De Michele, University of Naples Federico II, Italy
Reviewed by: Benito de Celis Alonso, Benemérita Universidad Autónoma de Puebla, Mexico; Roberto Ceravolo, Univeristy of Pisa, Italy
This article was submitted to Movement Disorders, a section of the journal Frontiers in Neurology
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2019.00101